Position in RGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,414,699
-$10,295,593 QoQ
Shares Held
1,839,463
+3.0% QoQ
Ownership
3.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.90024262515746.ToString("F0")%
Shared 0.ToString("F0")%
None 0.09975737484254915.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. RGNX ranks #119 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in RGNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,414,699 | 1,839,463 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,710,292 | 1,785,437 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $17,873,864 | 1,852,214 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,650,793 | 1,784,506 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,381,997 | 752,727 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $5,845,719 | 756,238 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $7,798,129 | 743,387 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,596,143 | 649,243 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $15,246,357 | 723,605 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,033,102 | 336,106 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $9,824,216 | 596,854 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $11,593,779 | 579,979 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $10,527,404 | 556,711 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $13,527,893 | 596,468 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $16,681,637 | 631,163 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $12,353,087 | 500,125 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $3,952,198 | 119,078 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,449,186 | 319,547 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $15,776,255 | 376,342 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $14,887,474 | 383,204 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,311,219 | 360,927 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $33,098,783 | 729,691 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,676,856 | 533,316 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $22,125,769 | 600,754 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $20,652,125 | 637,805 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||